P-ISSN 0002-4678
E-ISSN 2162-4151
Vol. 73, Issue 1, 2010January 01, 2010 EDT
BIG BAD PHARMA: AN ETHICAL ANALYSIS OF PHYSICIAN-DIRECTED AND CONSUMER-DIRECTED MARKETING TACTICS
BIG BAD PHARMA: AN ETHICAL ANALYSIS OF PHYSICIAN-DIRECTED AND CONSUMER-DIRECTED MARKETING TACTICS
Amanda L. Connors,
pharmaceutical manufacturersfiduciary dutydirect-to-consumer advertisementsmedical advertisingbig pharmame-too drugs
Articles in Vol. 73, Issue 1, 2010
Vol. 73, Issue 1, 2010
- LEGAL AUTOPSIES: ASSESSING THE PERFORMANCE OF JUDGES AND LAWYERS THROUGH THE WINDOW OF LEADING CONTRACT CASESGerald Caplan
- ETHICS OF LAWYER SOCIAL NETWORKINGSteven C. Bennett
- TO (B) OR NOT TO (B): IS THAT THE QUESTION? TWENTY-FIRST CENTURY SCHIZOID PLANS UNDER SECTION 403(B) OF THE INTERNAL REVENUE CODEDavid Pratt
- BIG BAD PHARMA: AN ETHICAL ANALYSIS OF PHYSICIAN-DIRECTED AND CONSUMER-DIRECTED MARKETING TACTICSAmanda L. Connors
- PLAYING THE ODDS OR PLAYING GOD? LIMITING PARENTAL ABILITY TO CREATE DISABLED CHILDREN THROUGH PREIMPLANTATION GENETIC DIAGNOSISKaren E. Schiavone
- A SAFE HARBOR FOR DRUGS MADE OFFSHORE: THE FEDERAL CIRCUIT RENDERS THE BOLAR AMENDMENT AVAILABLE IN § 337 ACTIONS IN AMGEN V. U.S. INTERNATIONAL TRADE COMMISSIONTeige P Sheehan
- ANNOYANCETECH VIGILANTE TORTS AND POLICYRobert F. Blomquist
- THE EXTRAPOLATION OF DEFENDANTS’ LIABILITIES UNDER CPLR ARTICLE 16 WHERE THE PLAINTIFF IS CONTRIBUTORILY NEGLIGENT: AN UPDATE TOWARD RESOLVING A PERCEIVED AMBIGUITY OF CPLR 1601Mark C. Dillon
- CPLR 3211(A)(7): DEMURRER OR MERITS-TESTING DEVICE?John R. Higgitt
Amanda L. Connors, BIG BAD PHARMA: AN ETHICAL ANALYSIS OF PHYSICIAN-DIRECTED AND CONSUMER-DIRECTED MARKETING TACTICS, 73 Albany Law Review (2010).